Autopsy report · NCT00766636

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow Accrual”

The sponsor’s own words in the registry.

Life of this trial

5 participants enrolled.
Results were posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: M.D. Anderson Cancer Center
Sponsor type: University, hospital or other
Conditions: Pancreatic Cancer
Interventions: Gemcitabine; Radiation Therapy; Erlotinib; Surgery
Participants: 5
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.